STOCK TITAN

American Picture House issues going-concern warning

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

American Picture House Corp. (APHP) reported $1,220 in revenue and a $349,421 net loss for the nine months ended September 30, 2026, compared with no revenue and a $1,355,022 net loss a year earlier. Net cash used in operating activities was $84,124, versus $325,877. At quarter-end, APHP had no cash, a $1,548,881 working capital deficit and an $8.2 million accumulated deficit; management said these conditions raise substantial doubt about continuing as a going concern.

Under its BECKY 3 agreement, APHP is entitled to a $360,000 senior equity recoupment preference in exchange for 250,000 shares. Options to buy 300,000 shares at $0.20 each had not been issued, and no recoupment had been collected as of the report date. A Labrys standstill is conditioned on paying $114,081.63 by November 20, 2026 to retire a prior note and the forbearance fee. If unpaid, Labrys stated it would convert on November 23 and treat both notes as in default; the January note’s $172,500 principal remained outstanding.

Disclosure controls were ineffective at September 30, 2026 because of previously reported material weaknesses. Remediation remained ongoing and depended in part on obtaining additional capital.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 3 points

How the balance works

Positive

  • Moderate pointNine-month net loss declined to $349,421 from $1,355,022.
  • Moderate pointNine-month operating cash used declined to $84,124 from $325,877.

Negative

  • Major pointGoing-concern warning: $1,548,881 working capital deficit and no cash at quarter-end.
  • Major pointDisclosure controls remained ineffective at September 30, 2026 due to material weaknesses.
  • Moderate pointScheduled Labrys amortization payments were missed; $172,500 principal remained outstanding. 3% of market cap

Filing Explained

APHP issued additional common shares, reducing existing holders’ ownership percentages; it also applied $875,000 of receivables noncash to film obligations.

On August 6, 2026, APHP issued 680,000 additional common shares: 600,000 sold for $60,000 gross and 80,000 issued for services. Those issuances increased the common share count, reducing existing holders’ percentage ownership absent offsetting changes. Across the quarter’s 930,000 shares issued, the filing says the total represented less than 1% of outstanding common stock; the $60,000 proceeds were for general working capital.

Separately, during the nine months ended September 30, 2026, APHP applied $875,000 of amounts otherwise receivable toward obligations under its SSS multi-film agreement, receiving content interests for MOTION and an untitled SSS-produced picture and partly satisfying amounts payable for POSE, without cash changing hands.

The report also states that scheduled amortization payments under the January 20, 2026 Labrys note were not made when due.

Nine-month revenue $1,220 Nine months ended September 30, 2026; compared with $0 in 2025.
Nine-month net loss $349,421 Nine months ended September 30, 2026; compared with $1,355,022 in 2025.
Net cash used in operating activities $84,124 Nine months ended September 30, 2026; compared with $325,877 in 2025.
Cash and cash equivalents $0 As of September 30, 2026.
Working capital deficit $1,548,881 As of September 30, 2026.
Senior equity recoupment preference $360,000 BECKY 3 agreement; no amounts had been collected as of the report date.
Labrys standstill payment $114,081.63 Payment required by November 20, 2026 under the standstill terms.
January Labrys note principal $172,500 Principal remained outstanding as of the report date.
going concern financial
"raise substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
working capital deficit financial
"we had a working capital deficit of $1,548,881"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
senior equity recoupment preference financial
"collected no amounts in respect of its senior equity recoupment preference"
cash asset management agreement financial
"income from the BUFFALOED CAMA"
forbearance fee financial
"a forbearance fee of $27,500"
material weaknesses regulatory
"due to the material weaknesses previously disclosed"
Material weaknesses are significant flaws in a company’s systems for ensuring its financial reports are accurate and reliable. Like a broken lock on a safe, they increase the chance that financial statements contain big errors or omissions, which can mislead investors about performance and risk; discovering one often raises questions about management oversight, may lead to restated results, and can affect investor confidence and a company’s valuation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were APHP’s revenue and net loss for the first nine months of 2026?

APHP reported $1,220 in revenue and a $349,421 net loss for the nine months ended September 30, 2026. For the same period in 2025, it reported no revenue and a $1,355,022 net loss.

What did APHP report about its cash and going-concern status?

At September 30, 2026, APHP had no cash and a $1,548,881 working capital deficit. Management said these conditions raise substantial doubt about the company’s ability to continue as a going concern within one year after the financial statements are issued.

What payment is required for APHP’s Labrys standstill?

APHP must pay $114,081.63 by November 20, 2026 to retire a prior Labrys note and the forbearance fee. Labrys agreed to take no action under either note through that date on those terms. If payment is not received, Labrys stated it will convert on November 23 and treat both notes as in default.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 Q3 0001771995 0001771995 2026-01-01 2026-09-30 0001771995 2026-11-13 0001771995 2026-09-30 0001771995 2025-12-31 0001771995 us-gaap:RelatedPartyMember 2026-09-30 0001771995 us-gaap:RelatedPartyMember 2025-12-31 0001771995 us-gaap:NonrelatedPartyMember 2026-09-30 0001771995 us-gaap:NonrelatedPartyMember 2025-12-31 0001771995 2026-07-01 2026-09-30 0001771995 2025-07-01 2025-09-30 0001771995 2025-01-01 2025-09-30 0001771995 us-gaap:CommonStockMember 2024-12-31 0001771995 us-gaap:PreferredStockMember 2024-12-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001771995 us-gaap:RetainedEarningsMember 2024-12-31 0001771995 2024-12-31 0001771995 us-gaap:CommonStockMember 2025-03-31 0001771995 us-gaap:PreferredStockMember 2025-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001771995 us-gaap:RetainedEarningsMember 2025-03-31 0001771995 2025-03-31 0001771995 us-gaap:CommonStockMember 2025-06-30 0001771995 us-gaap:PreferredStockMember 2025-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001771995 us-gaap:RetainedEarningsMember 2025-06-30 0001771995 2025-06-30 0001771995 us-gaap:CommonStockMember 2025-12-31 0001771995 us-gaap:PreferredStockMember 2025-12-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001771995 us-gaap:RetainedEarningsMember 2025-12-31 0001771995 us-gaap:CommonStockMember 2026-03-31 0001771995 us-gaap:PreferredStockMember 2026-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001771995 us-gaap:RetainedEarningsMember 2026-03-31 0001771995 2026-03-31 0001771995 us-gaap:CommonStockMember 2026-06-30 0001771995 us-gaap:PreferredStockMember 2026-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001771995 us-gaap:RetainedEarningsMember 2026-06-30 0001771995 2026-06-30 0001771995 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001771995 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001771995 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001771995 2025-01-01 2025-03-31 0001771995 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001771995 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001771995 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001771995 2025-04-01 2025-06-30 0001771995 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001771995 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001771995 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001771995 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001771995 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001771995 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001771995 2026-01-01 2026-03-31 0001771995 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001771995 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001771995 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001771995 2026-04-01 2026-06-30 0001771995 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001771995 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001771995 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001771995 us-gaap:CommonStockMember 2025-09-30 0001771995 us-gaap:PreferredStockMember 2025-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001771995 us-gaap:RetainedEarningsMember 2025-09-30 0001771995 2025-09-30 0001771995 us-gaap:CommonStockMember 2026-09-30 0001771995 us-gaap:PreferredStockMember 2026-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001771995 us-gaap:RetainedEarningsMember 2026-09-30 0001771995 us-gaap:AccountsReceivableMember APHP:CustomerMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0001771995 us-gaap:AccountsReceivableMember APHP:CustomerMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2022-11-30 0001771995 APHP:CashAssetManagementAgreementMember 2026-07-01 2026-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2025-07-01 2025-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2026-01-01 2026-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2025-01-01 2025-09-30 0001771995 2025-12-29 2025-12-29 0001771995 2025-12-29 0001771995 APHP:MasterInvestmentAndCoProductionAgreementMember 2026-05-26 0001771995 APHP:MasterInvestmentAndCoProductionAgreementMember 2026-05-25 2026-05-26 0001771995 APHP:MasterInvestmentAndCoProductionAgreementMember 2026-08-26 0001771995 APHP:MasterInvestmentAndCoProductionAgreementMember 2026-07-01 2026-09-30 0001771995 APHP:MultiFilmInvestmentAndCompensationAgreementMember 2026-01-01 2026-09-30 0001771995 APHP:ConsultingServicesMember 2026-07-01 2026-09-30 0001771995 APHP:ConsultingServicesMember 2025-07-01 2025-09-30 0001771995 APHP:ConsultingServicesMember 2026-01-01 2026-09-30 0001771995 APHP:ConsultingServicesMember 2025-01-01 2025-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2026-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2025-12-31 0001771995 APHP:CollectionServiceFeesAgreementMember 2026-09-30 0001771995 APHP:CollectionServiceFeesAgreementMember 2025-12-31 0001771995 us-gaap:ConvertiblePreferredStockMember 2026-01-01 2026-09-30 0001771995 us-gaap:ConvertiblePreferredStockMember 2025-01-01 2025-12-31 0001771995 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-09-30 0001771995 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-12-31 0001771995 2025-01-01 2025-12-31 0001771995 APHP:EconomicInjuryDisasterLoanMember 2026-09-30 0001771995 APHP:EconomicInjuryDisasterLoanMember 2025-12-31 0001771995 APHP:EconomicInjuryDisasterLoanMember 2025-01-01 2025-12-31 0001771995 srt:MinimumMember 2026-01-01 2026-09-30 0001771995 srt:MaximumMember 2026-01-01 2026-09-30 0001771995 APHP:SecuritiesPurchaseAgreementMember 2026-01-20 0001771995 APHP:SecuritiesPurchaseAgreementMember 2026-01-20 2026-01-20 0001771995 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001771995 APHP:SecuritiesPurchaseAgreementMember 2026-09-30 0001771995 APHP:SecuritiesPurchaseAgreementMember APHP:PromissoryNoteMember 2026-09-30 0001771995 APHP:SecuritiesPurchaseAgreementMember APHP:QuickCapitalLLCMember 2026-04-17 0001771995 APHP:SecuritiesPurchaseAgreementMember APHP:QuickCapitalLLCMember 2026-04-17 2026-04-17 0001771995 APHP:MasterLoanAgreementMember APHP:MrMacgregorMember 2026-09-30 0001771995 APHP:MasterLoanAgreementMember APHP:MrMacgregorMember 2026-07-01 2026-09-30 0001771995 APHP:MasterLoanAgreementMember APHP:MrMacgregorMember 2026-01-01 2026-09-30 0001771995 APHP:MasterLoanAgreementMember APHP:MrMacgregorMember 2025-12-31 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2026-09-30 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2026-01-01 2026-09-30 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2025-12-31 0001771995 us-gaap:SeriesAPreferredStockMember 2026-09-30 0001771995 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001771995 us-gaap:SubsequentEventMember 2026-11-13 0001771995 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2026-11-13 0001771995 us-gaap:CommonStockMember 2026-08-06 2026-08-06 0001771995 APHP:Becky3MasterInvestmentMember 2026-08-06 2026-08-06 0001771995 APHP:ThreeHoldersMember 2026-08-06 2026-08-06 0001771995 APHP:TwoPurchasersMember 2026-08-06 2026-08-06 0001771995 APHP:TwoPurchasersMember 2026-08-06 0001771995 2026-08-06 2026-08-06 0001771995 APHP:BoardOfDirectorsMember 2026-01-01 2026-09-30 0001771995 us-gaap:CommonStockMember 2026-08-06 0001771995 APHP:Becky3MasterInvestmentMember 2026-07-01 2026-09-30 0001771995 APHP:Becky3MasterInvestmentMember 2026-09-30 0001771995 APHP:SSSEntertainmentLLCMember 2026-01-01 2026-09-30 0001771995 APHP:SSSEntertainmentLLCMember 2026-09-30 0001771995 APHP:FourDesigneesMember 2026-01-01 2026-09-30 0001771995 APHP:Becky3MasterInvestmentMember 2026-08-06 0001771995 us-gaap:SettledLitigationMember APHP:JanuaryTwoThousandAndTwentyFourAgreementMember 2026-08-18 2026-08-18 0001771995 us-gaap:DamagesFromProductDefectsMember APHP:JanuaryTwoThousandAndTwentyFourAgreementMember 2026-08-18 2026-08-18 0001771995 APHP:Becky3MasterInvestmentMember 2026-06-03 2026-06-03 0001771995 APHP:Becky3MasterInvestmentMember srt:MaximumMember 2026-06-03 2026-06-03 0001771995 APHP:Becky3MasterInvestmentMember 2026-06-03 0001771995 APHP:LegalFirmMember 2025-07-01 2025-09-30 0001771995 APHP:LegalFirmMember 2025-01-01 2025-09-30 0001771995 APHP:LegalFirmMember 2026-09-30 0001771995 APHP:LegalFirmMember 2025-12-31 0001771995 APHP:ConsultingServicesMember 2026-07-01 2026-09-30 0001771995 APHP:ConsultingServicesMember 2025-07-01 2025-09-30 0001771995 APHP:ConsultingServicesMember 2026-01-01 2026-09-30 0001771995 APHP:ConsultingServicesMember 2025-01-01 2025-09-30 0001771995 APHP:BoardOfDirectorsMember 2026-08-06 2026-08-06 0001771995 APHP:BoardOfDirectorsMember 2026-08-06 0001771995 srt:ChiefExecutiveOfficerMember 2026-08-06 2026-08-06 0001771995 srt:ChiefExecutiveOfficerMember 2026-08-06 0001771995 us-gaap:SubsequentEventMember APHP:PromissoryNoteMember 2026-10-19 0001771995 us-gaap:SubsequentEventMember APHP:PromissoryNoteMember 2026-10-19 2026-10-19 0001771995 APHP:PromissoryNoteMember 2026-01-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure APHP:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

COMMISSION FILE NO. 000-56586

 

American Picture House Corporation

(Exact name of registrant as specified in its charter)

 

Wyoming   7812   85-4154740
(State or another jurisdiction of incorporation)   (Primary Standard Industrial Classification Code Number)   (I.R.S. Employer Identification No.)

 

477 Madison Avenue, 6th Floor

New York, NY 10022

1-877-416-5558

(Address and telephone number of registrant’s executive office)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   N/A   N/A

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 13, 2026, the Registrant had 114,691,925 shares of common stock issued and outstanding.

 

 

 

 
 

 

AMERICAN PICTURE HOUSE CORPORATION

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

GENERAL AND WHERE YOU CAN FIND MORE INFORMATION 1
PART I FINANCIAL INFORMATION F-1
ITEM 1. FINANCIAL STATEMENTS (unaudited) F-1
CONDENSED CONSOLIDATED BALANCE SHEETS – SEPTEMBER 30, 2026 AND DECEMBER 31, 2025 F-2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS – THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 F-3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) – THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 F-4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS – NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 F-5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS F-6
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 2
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 5
ITEM 4. CONTROLS AND PROCEDURES 5
PART II OTHER INFORMATION 6
ITEM 1. LEGAL PROCEEDINGS 6
ITEM 1A. RISK FACTORS 6
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 6
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 7
ITEM 4. MINE SAFETY DISCLOSURES 7
ITEM 5. OTHER INFORMATION 7
ITEM 6. EXHIBITS 7
SIGNATURES 8

 

 
 

 

GENERAL AND WHERE YOU CAN FIND MORE INFORMATION

 

Unless otherwise indicated, all references to the “Company,” “we,” “our,” and “APHP” refer to American Picture House Corporation, a Wyoming corporation. References to “revenues” refer to net revenues. References to “U.S. dollars,” “dollars,” “U.S.$” and “$” are to the lawful currency of the United States of America.

 

1
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2026

 

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidated Balance Sheets, September 30, 2026 and December 31, 2025 F-2
Condensed Consolidated Statements of Operations, for the three and nine months ended September 30, 2026 and 2025 F-3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit), for the three and nine months ended September 30, 2026 and 2025 F-4
Condensed Consolidated Statements of Cash Flows, for the nine months ended September 30, 2026 and 2025 F-5
Notes to Condensed Consolidated Financial Statements F-6

 

F-1

 

 

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   September 30, 2026   December 31, 2025 
ASSETS          
Current Assets          
Cash and cash equivalents  $-   $124 
Accounts receivable   121,816    1,150,000 
Prepaid expenses   8,464    28,375 
Receivable - related party   -    - 
Total Current Assets   130,280    1,178,499 
           
Produced and licensed content costs   1,212,500    300,000 
Loans receivable, film financing arrangements   -    - 
Intangible assets, net of accumulated amortization of $60,083 and $42,583 as of September 30, 2026 and December 31, 2025, respectively.   9,917    27,417 
           
TOTAL ASSETS   1,352,697    1,505,916 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current Liabilities          
Cash overdraft   737    - 
Accounts payable and accrued expenses   656,826    655,163 
Deferred revenue, current portion   50,000    50,000 
Interest payable - related party   41,107    42,200 
Interest payable - EIDL loan   3,735    6,086 
Interest payable - Notes Payable   48,396    - 
Note payable   288,954    115,000 
Note payable - related party   491,501    647,209 
Commercial Line of Credit   97,905    97,905 
           
Total Current Liabilities   1,679,161    1,613,563 
           
Economic injury disaster loan, non-current   149,900    149,900 
           
Total Liabilities   1,829,061    1,763,463 
           
Stockholders’ Equity (Deficit):          
Common Stock $0.0001 par value. 1,000,000,000 authorized. 114,691,925 and 113,399,325 issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.   11,469    11,340 
Preferred Stock $0.0001 par value. 1,000,000 authorized. 3,839 issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.   -    - 
Additional paid in capital   7,687,982    7,557,507 
Accumulated deficit   (8,175,815)   (7,826,394)
Total Stockholders’ Equity (Deficit)   (476,364)   (257,547)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $1,352,697   $1,505,916 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-2

 

 

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   2026   2025   2026   2025 
   Three months ended September 30,   Nine months ended September 30, 
   2026   2025   2026   2025 
                 
Revenues  $-   $-   $1,220   $- 
                     
Cost of revenues   -    -    -    - 
Gross profit   -    -    1,220    - 
                     
Operating Expenses:                    
General and administrative   38,240    67,743    207,377    1,293,606 
Research and development   -    -    -    - 
Sales and marketing   364    7,027    4,150    8,857 
Total Operating Expenses   38,604    74,770    211,527    1,302,463 
Net Operating Loss   (38,604)   (74,770)   (210,307)   (1,302,463)
                     
Other Income (Expenses):                    
Interest income   -    -    -    44 
Interest expense   (68,120)   (30,787)   (139,114)   (52,603)
Net Other Income (Expenses)   (68,120)   (30,787)   (139,114)   (52,559)
Loss before income taxes   (106,724)   (105,557)   (349,421)   (1,355,022)
Income taxes   -    -    -    - 
Net loss  $(106,724)  $(105,557)  $(349,421)  $(1,355,022)
                     
                     
Net loss per common share - Basic and Diluted  $(0.00)  $(0.00)  $(0.00)  $(0.01)
                     
Weighted average shares used in per share computation - Basic and Diluted   114,317,903    112,899,325    113,881,109    112,573,318 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-3

 

 

AMERICAN PICTURE HOUSE CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the nine months ended September 30, 2026 and 2025

(Unaudited)

 

   Shares  

Par

Value

   Shares   Amount  

Paid In

Capital

   Accumulated Deficit  

Equity

(Deficit)

 
   Common Stock   Preferred Stock   Additional        Total Stockholders’ 
   Shares  

Par

Value

   Shares   Amount  

Paid In

Capital

   Accumulated Deficit  

Equity

(Deficit)

 
                             
Balance, December 31, 2024   112,399,325   $11,240    3,829   $-   $7,264,042   $(7,291,954)  $(16,672)
                                    
Preferred stock redeemed in exchange for assets   -    -    (10)   -    (256,000)   -    (256,000)
                                    
Stock option compensation   -    -    -    -    232,995    -    232,995 
                                    
Net Loss   -    -    -    -    -    (488,837)   (488,837)
                                    
Balance, March 31, 2025   112,399,325   $11,240    3,819   $-   $7,241,037   $(7,780,791)  $(528,514)
                                    
Common Stock issued for services   500,000    50    20    -    109,950    -    110,000 
                                    
Stock option compensation   -    -    -    -    73,035    -    73,035 
                                    
Net Loss   -    -    -    -    -    (760,628)   (760,628)
                                    
Balance, June 30, 2025   112,899,325   $11,290    3,839   $-   $7,424,022   $(8,541,419)  $(1,106,107)
                                    
Stock option compensation   -    -    -    -    73,035    -    73,035 
                                    
Net Loss   -    -    -    -    -    (105,557)   (105,557)
                                    
Balance, September 30, 2025   112,899,325   $11,290    3,839   $-   $7,497,057   $(8,646,976)  $(1,138,629)

 

   Common Stock   Preferred Stock   Additional       Total Stockholders’ 
   Shares  

Par

Value

   Shares   Amount  

Paid In

Capital

   Accumulated Deficit  

Equity

(Deficit)

 
                             
Balance, December 31, 2025   113,399,325   $11,340    3,839   $-   $7,557,507   $(7,826,394)  $(257,547)
                                    
Financing costs settled in shares of stock   200,000    20    -    -    15,980    -    16,000 
                                    
Note payable ($5,754) and financing costs ($1,750) settled in shares of stock   162,600    16    -    -    7,488    -    7,504 
                                    
Net Loss   -    -    -    -    -    (171,239)   (171,239)
                                    
Balance, March 31, 2026   113,761,925   $11,376    3,839   $-   $7,580,975   $(7,997,633)  $(405,282)
                                    
Net Loss   -    -    -    -    -    (71,458)   (71,458)
                                    
Balance, June 30, 2026   113,761,925   $11,376    3,839   $-   $7,580,975   $(8,069,091)  $(476,740)
                                    
Issuance of Common Stock   600,000    60    -    -    59,940    -    60,000 
                                    
Common stock issued for Licensed Content   250,000    25    -    -    37,475    -    37,500 
                                    
Common Stock issued for services   80,000    8    -    -    9,592    -    9,600 
                                    
Net Loss   -    -    -    -    -    (106,724)   (106,724)
                                    
Balance, September 30, 2026   114,691,925   $11,469    3,839   $-   $7,687,982   $(8,175,815)  $(476,364)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-4

 

 

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2026   2025 
   Nine months ended September 30, 
   2026   2025 
Cash Flows from Operating Activities:          
Net Income (Loss)  $(349,421)  $(1,355,022)
Adjustments to Reconcile Net Income (Loss) to Net Cash Flows from Operating Activities:          
Reserve for uncollectible receivable   -    196,200 
Expiration of produced and licensed costs   -    150,834 
Stock option expense   -    379,065 
Common stock issued for services   9,600    110,000 
Common Stock issued for Produced and Licensed Content   37,500    - 
Preferred stock redeemed in exchange for assets   -    (42,642)
Note payable converted to equity   (5,754)   - 
Financing costs paid in shares of common stock   23,504    - 
Amortization expense   17,500    17,500 
Change in operating assets and liabilities:          
Accounts receivable   1,028,184    29,674 
Prepaid expenses   19,911    (15,677)
Receivables - related party   -    4,086 
Loans receivable, film financing arrangements   -    - 
Produced and licensed costs   (912,500)   (1,200)
Cash overdraft   737    (21)
Accounts payable and accrued expenses   1,663    184,551 
Interest payable - Notes Payable   48,396    - 
Interest payable - related parties   (1,093)   19,385 
Interest payable - EIDL loan   (2,351)   (2,610)
Deferred revenue   -    - 
Net Cash Flows from Operating Activities   (84,124)   (325,877)
           
Cash Flows from Investing Activities:          
Intangible assets   -    - 
Net Cash Flows from Investing Activities   -    - 
           
Cash Flows from Financing Activities:          
Proceeds from issuance of note payable   -    - 
Proceeds from debt borrowings - related parties   9,095    331,821 
Repayment of debt borrowings - related parties   (164,803)   (20,119)
Proceeds from commercial line of credit   -    1,050 
Repayments on commercial line of credit   -    - 
Proceeds from note payable   215,250    115,000 
Repayment of note payable   (35,542)   - 
Proceeds from sale of Common Stock   60,000    - 
Net Cash Flows from Financing Activities   84,000    427,752 
           
Net Increase in Cash and Cash Equivalents   (124)   101,875 
Cash and Cash Equivalents, Beginning of Period   124    - 
Cash and Cash Equivalents, End of Period  $-   $101,875 
   $      
Non-cash Financing and Investing Activities:          
Notes payable converted to Common Stock   -    - 
Financing costs paid in Common Stock   -    - 
Common Stock issued for services   9,600    110,000 
Common Stock issued for Produced and licensed costs   37,500    - 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

F-5

 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – Organization and Description of Business

 

American Picture House Corporation (the “Company,” “we,” “APHP,” and “us”) was incorporated in the State of Nevada on September 21, 2005, originally under the corporate name of Servinational, Inc. The Company subsequently changed its name to Shikisai International, Inc. in November 2005 and then to Life Design Station, Intl., Inc. in August 2007. The Company changed its state of domicile from Nevada to Wyoming on October 13, 2020. On December 4, 2020, the Company changed its name to American Picture House Corporation. The Company’s year-end is December 31.

 

APHP is an entertainment company focused on the development, packaging, financing and production of feature films and limited series. During 2025, the Company pivoted away from third-party consulting to concentrate on internally developed projects and selective strategic partnerships. As of September 30, 2026, APHP’s project participation includes BARRON’S COVE, POSE, THIEVES HIGHWAY, PROTECTOR, MOTION and THE LAST TEMPTATION OF BECKY. BARRON’S COVE, POSE and THIEVES HIGHWAY were released in 2025; PROTECTOR was released in U.S. theaters on March 6, 2026; THE LAST TEMPTATION OF BECKY had its world premiere on July 25, 2026 and was released theatrically on November 4, 2026; MOTION was in post-production as of September 30, 2026.

 

The Company had no employees as of September 30, 2026 and continued to rely on consultants and other independent contractors for corporate operations and project-level activities.

 

NOTE 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP and pursuant to the rules and regulations of the Securities and Exchange Commission applicable to interim financial statements. In the opinion of management, the interim financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the interim periods presented. The results for the interim period are not necessarily indicative of the results to be expected for the full year ending December 31, 2026. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2025.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of American Picture House Corporation and its wholly owned subsidiaries, Devil’s Half-Acre, LLC and Ask Christine Productions, LLC. All intercompany balances and transactions have been eliminated in consolidation. The Company dissolved Devil’s Half-Acre, LLC and Ask Christine Productions, LLC on May 12, 2025.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

 

Cash and Cash Equivalents

 

Cash equivalents are short-term highly liquid investments with original maturities of three months or less when acquired. Checks issued in excess of available bank balances are classified as a book overdraft within accounts payable and accrued expenses.

 

Accounts Receivable

 

Accounts receivable primarily consist of trade receivables due from customers for consulting services and from fees derived from licensing of IP to content providers worldwide. As of September 30, 2026, accounts receivable was related to the BUFFALOED CAMA (see Assigned Rights to feature film, BUFFALOED below) and collection service fees related to the Company’s contractual revenue collection rights to BARRON’S COVE. As of December 31, 2025, 100% of accounts receivable were due from collection service fees related to the Company’s contractual revenue collection rights under Amendment No. 1, dated December 29, 2025, to the Company’s agreement relating to BARRON’S COVE. Under that amendment, the Company is entitled to receive 100% of Net Revenues until it has received an aggregate of $1,150,000 (the “APHP Priority Amount”).

 

F-6

 

 

There was no bad debt expense for the three and nine months ended September 30, 2026 and 2025 and no additional allowance for doubtful accounts for the periods ended September 30, 2026 and December 31, 2025.

 

Schedule of Accounts Receivable

 

   September 30, 2026   December 31, 2025 
         
Accounts receivable, CAMA  $1,220   $- 
Accounts receivable, Collection Service Fees   120,596    1,150,000 
Accounts receivable  $121,816   $1,150,000 

 

Produced and Licensed Content Costs

 

Capitalized production costs, whether produced or acquired/licensed rights, include development costs, direct costs and production overhead, and are subject to impairment evaluation when events or circumstances indicate the carrying value may not be recoverable. These amounts and licensed content are included in “Produced and Licensed Content Costs” on the balance sheet as follows:

 

Schedule of Produced and Licensed Content Costs

 

   September 30, 2026   December 31, 2025 
Films in development and pre-production stage  $737,500   $- 
Films commercially released  $475,000   $300,000 
Produced and licensed content cost  $1,212,500   $300,000 

 

BUFFALOED. Completed; Released. In November 2022, the Company obtained certain limited rights to the feature film BUFFALOED from Bold Crayon, Inc. (“BC”), including a secured position of a one million three hundred eighty-thousand-dollar ($1,380,000.00 USD) receivable against the film’s revenues as per the film’s Cash Asset Management Agreement (“CAMA”) and a 35% share of the profits generated thereafter (“the BC Assets”). During the three months ended September 30, 2026 and 2025, the Company reported revenues of $0 and $0, respectively, from the CAMA. During the nine months ended September 30, 2026 and 2025, the Company reported revenues of $1,220 and $0, respectively, from the CAMA.

 

BARRON’S COVE. Completed; Released. APHP acquired a first-priority recoupment/loan position related to this title in August 2025. The film was released in the U.S. on June 6, 2025 by Well Go USA. As reported by the producer/sales agent, a three-year U.S. streaming license with Paramount+ was executed in early October 2025.

 

BARRON’S COVE. Revenue collection and inter-party allocation. On December 29, 2025, the Company entered into Amendment No. 1 to its agreement with SSS Entertainment, LLC (“SSS”), which sets forth inter-party revenue collection and allocation mechanics for amounts actually received by the Company from exploitation of BARRON’S COVE. Under the amendment, the Company is entitled to receive 100% of Net Revenues until it has received an aggregate $1,150,000, after which Net Revenues are allocated 85% to SSS and 15% to the Company until SSS has received the specified recoupment amount, and thereafter 100% of subsequent Net Revenues are retained by the Company. The amendment further acknowledges uncertainty relating to bankruptcy proceedings involving Yale Entertainment LLC and the potential impact on enforcement, priority, or timing of collections.

 

POSE. The Company’s POSE arrangement was restructured pursuant to the Multi-Film Investment and Compensation Agreement with SSS effective January 27, 2026.

 

THIEVES HIGHWAY. Completed; Released. APHP earned an “In Association With” credit.

 

F-7

 

 

PROTECTOR. Completed; Released. APHP earned an “In Association With” credit; PROTECTOR was released in U.S. theaters on March 6, 2026.

 

LAST TEMPTATION OF BECKY. Completed; Released. On May 26, 2026, the Company entered into a Master Investment and Co-Production Agreement with Becky III The Movie LLC and Russell Posternak (executed June 3, 2026) relating to the motion picture THE LAST TEMPTATION OF BECKY (referred to in the agreement as “BECKY 3”). Under the agreement, the Company is entitled to a $360,000 senior equity recoupment preference, a participation in distribution fees, and related co-production and credit rights, in consideration of 250,000 shares of common stock and options to purchase 300,000 shares of common stock at an exercise price of $0.20 per share. The shares were issued on August 6, 2026. The 250,000 shares were recorded at $0.15 per share, or $37,500, which was capitalized as produced and licensed content costs. See Note 6 and Note 7. The picture had its world premiere at the Fantasia International Film Festival in Montreal on July 25, 2026 and was released theatrically on November 4, 2026 by Quiver Distribution. As of the date of this report, the Company had collected no amounts in respect of its senior equity recoupment preference.

 

MOTION. In post-production. Pursuant to the Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC effective January 27, 2026, the Company agreed to provide a $500,000 funding amount relating to MOTION in exchange for an assigned economic interest attributable to such funding. The Company satisfied this funding obligation during the nine months ended September 30, 2026 on a non-cash basis, and the related content interest is included in produced and licensed content costs at September 30, 2026. The Company is entitled to a production company credit pursuant to applicable agreements. As of the date of this report, no release date had been announced.

 

Intangible assets

 

The Company’s intangible assets include in-service and under-development websites and licensed internal use software. The capitalized costs of the Company’s websites placed into service were subject to straight-line amortization over a three-year period. Amortization expense totaled $5,833 and $5,833 for the three months ended September 30, 2026 and 2025, respectively. Amortization expense totaled $17,500 and $17,500 for the nine months ended September 30, 2026 and 2025, respectively.

 

Deferred Revenue

 

Deferred revenue represents the amount billed to clients that has not yet been earned, pursuant to agreements entered into in current and prior periods. As of September 30, 2026 and December 31, 2025, total net deferred revenue was $50,000 and $50,000, respectively. The $50,000 in deferred revenue relates to the grant of a producer credit to a proposed film.

 

Revenues and Costs from Services and Products

 

The Company’s revenue is derived from contracts with customers for consulting services and from the licensing and distribution of film and other entertainment rights. The Company has elected the ASC 606 “as invoiced” practical expedient with respect to its consulting services revenue. Revenue from films and licensed rights, including amounts received under cash asset management arrangements, is recognized when collection is deemed probable; ultimate revenues are estimated over a period not to exceed ten years following the date of initial release of the motion picture. Cost of revenues includes only those costs directly related to the services rendered. Revenues totaled $0 and $0 for the three months ended September 30, 2026 and 2025, respectively, and $1,220 and $0 for the nine months ended September 30, 2026 and 2025, respectively. All revenue recognized during the three and nine months ended September 30, 2026 and 2025 was derived from film and licensed rights arrangements; the Company had no consulting services revenue in either period. Contract liabilities consist solely of deferred revenue as disclosed above; the Company had no contract assets at September 30, 2026 or December 31, 2025.

 

Fair Value Measurements

 

The Company measures and discloses fair value in accordance with ASC Topic 820, Fair Value Measurements and Disclosures. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three-tier fair-value hierarchy prioritizes the inputs used in measuring fair value: Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – observable inputs other than quoted prices; and Level 3 – unobservable inputs. The carrying value of cash and cash equivalents and all other short-term monetary assets and liabilities are estimated to approximate their fair value due to the short-term nature of these instruments.

 

F-8

 

 

Valuation of Long-Lived Assets

 

The Company evaluates whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally produced and licensed content costs) may be impaired or not recoverable, and measures impairment based on the projected discounted cash flows of the asset over its remaining life.

 

Stock-Based Compensation

 

The Company follows U.S. GAAP, which requires all stock-based compensation, including the grant of employee stock options, to be recognized in the statement of operations based on its fair value, recognized on a straight-line basis over the service period of each award. Refer to Note 6 for additional information.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, measured using enacted tax rates. A tax position must be more-likely-than-not to be sustained upon examination for the related benefit to be recognized. The Company assesses its uncertain tax positions quarterly.

 

Net Loss Per Share

 

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per common share reflects the potential dilution from common stock equivalents only to the extent they are not anti-dilutive. For the three and nine months ended September 30, 2026, potentially dilutive securities included Series A preferred shares and outstanding stock options.

 

Schedule of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Shares Outstanding

 

   September 30, 2026   December 31, 2025 
Convertible Preferred Stock   383,900,000    383,900,000 
Stock options   3,583,471    3,833,471 
    387,483,471    387,733,471 

 

In addition to the securities presented above, at September 30, 2026 the Company had outstanding convertible notes payable under which shares of common stock may be issued upon conversion. Because the conversion price is variable and is determined by reference to the market price of the Company’s common stock at the time of conversion, the number of shares issuable upon conversion is not determinable as of the reporting date and has therefore not been included in the table. The Company has reserved an initial 12,000,000 shares of common stock for potential issuance upon conversion of the notes, subject to adjustment in accordance with their terms. See Note 4.

 

Segment Information

 

The Company operates as one reportable segment. The Company’s Chief Executive Officer serves as the chief operating decision maker.

 

Recently Issued Accounting Pronouncements

 

Management has evaluated recently issued accounting pronouncements through the filing date of this Quarterly Report and determined that none are expected to have a material impact on the Company’s condensed consolidated financial statements.

 

NOTE 3 – Liquidity and Going Concern

 

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of September 30, 2026, the Company had a working capital deficit of approximately $1.5 million, an accumulated deficit of $8.2 million, and had no cash on hand and a book overdraft of $737. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.

 

Management’s current plan to address these conditions includes continued project monetization efforts, borrowings from related parties or third parties, equity issuances or equity-linked financings, and disciplined management of operating expenditures. There can be no assurance that these efforts will be successful.

 

F-9

 

 

NOTE 4 – Notes Payable

 

Economic Injury Disaster Loan

 

The Company’s EIDL obligation had a carrying value of $149,900 at September 30, 2026, with accrued interest of $3,735. The Company’s EIDL obligation had a carrying value of $149,900 at December 31, 2025, with accrued interest of $6,086. The loan bears interest at 3.75% per annum and is secured by substantially all of the Company’s tangible and intangible assets.

 

Commercial Line of Credit

 

The American Express line of credit balance was $97,905 at September 30, 2026 and $97,905 at December 31, 2025. Borrowings bear interest at rates ranging from approximately 16.09% to 34.3% and are personally guaranteed by Mr. MacGregor.

 

Convertible note financing (Labrys Fund II)

 

On January 20, 2026, the Company entered into a securities purchase agreement with Labrys Fund II, L.P. (“Labrys”) pursuant to which the Company issued a 10% promissory note in the aggregate principal amount of $172,500 (which includes an original issue discount of $22,500) in exchange for a cash purchase price of $150,000. The note has a twelve-month maturity from the issue date and contains conversion features subject to the note’s terms and limitations. As additional consideration, the Company agreed to issue 200,000 shares of common stock as commitment shares. The purchase price was disbursed such that $114,000 was wired to the Company, $7,500 was paid to the placement agent (Enclave Capital LLC), $25,000 was directed to the investor for repayment of a portion of a prior promissory note, and $3,500 was withheld for the investor’s legal fees. There were no additional borrowings under this note during the nine months ended September 30, 2026.

 

During the nine months ended September 30, 2026, Labrys converted $7,504 of amounts outstanding under its prior promissory note (including fees) into 162,600 shares of Common Stock at a conversion price of $0.04615 per share of Common Stock. There were no principal conversions during the quarter ended September 30, 2026.

 

During the quarter ended September 30, 2026, the 200,000 commitment shares issued in connection with the January 20, 2026 financing ceased to be held in restricted book-entry form with the Company’s transfer agent and became available for resale.

 

The January 20, 2026 note provides for scheduled amortization payments that commenced July 20, 2026. As of September 30, 2026 and as of the date of this report, the full principal amount of $172,500 remained outstanding; accrued interest as of the date of this report was $17,250. The Company also owed Labrys $85,204.35 of principal under a prior promissory note. See Note 9.

 

Convertible note financing (Quick Capital, LLC)

 

On April 17, 2026, the Company entered into a securities purchase agreement with Quick Capital, LLC (“Quick”) pursuant to which the Company issued a 12% promissory note in the aggregate principal amount of $31,250 (which includes an original issue discount of $3,750) in exchange for a cash purchase price of $27,500. The note matures on January 17, 2027 and contains conversion features subject to the note’s terms and limitations. The purchase price was disbursed such that $23,000 was wired to the Company, $2,000 was paid to the placement agent (Enclave Capital LLC), and $2,500 was withheld for the investor’s legal fees.

 

There were no conversions under this note during the nine months ended September 30, 2026.

 

NOTE 5 – Related Party Debt and Interest

 

Note Payable – Mr. MacGregor

 

The Company is party to a master loan agreement with Mr. MacGregor, its Chief Executive Officer, under which advances accrue interest at 4.4% per annum, payable in a lump sum at maturity, and are not convertible. During the three months ended September 30, 2026, the Company borrowed $6,469 from and repaid $34,493 of principal to Mr. MacGregor under this agreement. During the nine months ended September 30, 2026, the Company borrowed $9,095 from and repaid $164,803 of principal to Mr. MacGregor under this agreement. As of September 30, 2026, the Company owed Mr. MacGregor $182,501 of principal and $4,733 of accrued interest under this agreement. As of December 31, 2025, the Company owed Mr. MacGregor $338,209 of principal and $16,676 of accrued interest.

 

Noah Morgan Private Family Trust Loan Agreement (“NMPFT”)

 

The Company is party to a separate master loan agreement with The Noah Morgan Private Family Trust (“NMPFT”), a principal stockholder of the Company affiliated with Mr. MacGregor, under which advances accrue interest at 4.4% per annum, payable in a lump sum at maturity, and are not convertible. $200,000 of the proceeds advanced under this agreement were used to fund the senior mezzanine loan to Barron’s Cove Movie, LLC. During the nine months ended September 30, 2026, the Company did not borrow or repay any principal under this agreement. As of September 30, 2026, the Company owed NMPFT $309,000 of principal and $36,374 of accrued interest. As of December 31, 2025, the Company owed NMPFT $309,000 of principal and $25,524 of accrued interest.

 

F-10

 

 

NOTE 6 – Equity and Stock-Based Compensation

 

Authorized Capital. The Company has 1,000,000,000 common shares authorized and 1,000,000 preferred shares authorized, of which 100,000 are designated as Series A Convertible Preferred Stock.

 

Common and Preferred Shares. As of September 30, 2026 and December 31, 2025, the Company had 114,691,925 and 113,399,325 common shares and 3,839 and 3,839 Series A preferred shares issued and outstanding. As of November 13, 2026, the Company had 114,691,925 common shares and 3,839 Series A preferred shares issued and outstanding.

 

Share Issuances During the Quarter Ended September 30, 2026. On August 6, 2026, the Company issued an aggregate of 930,000 shares of common stock, consisting of 250,000 shares issued in connection with the BECKY 3 Master Investment and Co-Production Agreement described in Note 7 and 680,000 shares issued to three holders, consisting of 600,000 shares sold to two purchasers for cash at a price of $0.10 per share, for aggregate gross proceeds to the Company of $60,000, and 80,000 shares issued to a third holder as compensation for services rendered to the Company. Of the shares sold for cash, 500,000 shares, for aggregate proceeds of $50,000, were purchased by Timothy Battles, a member of the Company’s Board of Directors. The purchase price reflects a discount from the quoted closing price of the Company’s common stock on August 6, 2026 of $0.12 per share. The shares are restricted securities subject to a holding period under Rule 144 and bear customary restrictive legends. The shares issued for services were measured at the closing price of the Company’s common stock on the OTCQB Marketplace on August 6, 2026 of $0.12 per share, resulting in a charge of $9,600 that was recognized in the three months ended September 30, 2026. The 250,000 shares issued under the BECKY 3 agreement were recorded at $0.15 per share, the closing price of the Company’s common stock on the OTCQB Marketplace on May 26, 2026, the effective date of the agreement, resulting in aggregate consideration of $37,500 that was capitalized as produced and licensed content costs in the three months ended September 30, 2026. All such shares were issued as restricted securities bearing customary restrictive legends in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder, to recipients who represented investment intent, in transactions not involving any general solicitation.

 

Option grants to SSS Entertainment. The Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC contemplates the grant of nonqualified stock options to purchase an aggregate of 2,500,000 shares of common stock at an exercise price of $0.20 per share to Shaun Sanghani or his designees, assigns or nominees, subject to Board and/or committee approval, availability under the Company’s equity incentive plan, and execution of applicable award documentation. As of September 30, 2026 and the date of this report, none of these options had been granted. The grant of options to purchase 700,000 of these shares, consisting of 175,000 options to each of four designees of SSS Entertainment, LLC and expiring January 27, 2028, remains subject to the conditions described above. Because no options have been granted, no grant date has been established and no compensation cost has been recognized.

 

Stock Options. As of September 30, 2026 and December 31, 2025, 3,583,471 and 3,833,471 stock options, respectively, remained outstanding and exercisable. The Company agreed to grant options to purchase 300,000 shares of common stock at an exercise price of $0.20 per share, with a term expiring May 26, 2028, in connection with the BECKY 3 Master Investment and Co-Production Agreement described in Note 7. The options had not been issued as of September 30, 2026 or the date of this report and are not included in the stock options outstanding. When issued, the options will become exercisable only in proportion to the Company’s actual collection of its $360,000 senior equity recoupment entitlement, at a ratio of one option share for each $1.20 collected, and will be subject to a cashless exercise feature. No amounts had been collected as of the date of this report, and no expense has been recognized with respect to the options.

 

F-11

 

 

NOTE 7 – Commitments and Contingencies

 

Legal Proceedings. The Company is the respondent in a consolidated arbitration before JAMS in Los Angeles, California (Ref. No. 5220010741, consolidated with Ref. No. 5220010727), commenced in September 2025 by two entities affiliated with former consultants to the Company and seeking consulting fees claimed to be due under consulting agreements dated May 3, 2024. The Company disputes the claims and has objected to the commencement of the proceedings, service of the demands, the arbitrator appointment process and the consolidation.

 

On August 18, 2026, Ameriprise Financial, Inc. filed a complaint in the United States District Court for the District of Massachusetts (Case No. 1:26-cv-13816) against Barron’s Cove The Film, Inc., the Company and Mr. MacGregor. The complaint alleges that Barron’s Cove The Film, Inc. breached a January 2024 agreement to sell approximately $1.2 million of Massachusetts film tax credits to the plaintiff, for which the plaintiff alleges it paid $995,507.92. It includes separate claims against the Company and Mr. MacGregor arising out of alleged interference, as to which the complaint seeks injunctive relief relating to the tax credit certificate and damages, including treble damages under M.G.L. c. 93A.

 

The Company has not recorded a liability for these matters because it does not believe that a loss is probable. The Company is unable to estimate the amount or range of any reasonably possible loss in either matter.

 

Professional fee discussions (Aldous PLLC). The Company and Aldous PLLC entered into a tolling and standstill agreement effective March 1, 2026 with respect to outstanding professional fees. Draft settlement documentation, including a proposed settlement amount of $103,598.52, was circulated, but no final settlement agreement had been executed as of September 30, 2026.

 

BECKY 3 Master Investment and Co-Production Agreement. Effective May 26, 2026, and executed on June 3, 2026, the Company entered into a Master Investment and Co-Production Agreement and related ancillary agreements with Russ Posternak and Becky III The Movie LLC with respect to the motion picture BECKY 3. The Company is not obligated to fund any cash under the agreement. The Company is treated for economic purposes as having made a $300,000 senior equity investment in the picture, entitling it to recoup $360,000 out of the picture waterfall on a senior equity basis, pari passu with up to $300,000 of other senior equity, together with a distribution fee corridor participation, a participation in the producer’s future BECKY-related producer fees and backend, and an assignment of certain collateral recovery rights. As consideration, the Company agreed to issue 250,000 shares of common stock and to grant two-year options to purchase 300,000 shares of common stock at an exercise price of $0.20 per share, which options become exercisable proportionally as the Company collects its $360,000 recoupment entitlement. The shares were issued on August 6, 2026. The options had not been issued as of the date of this report. The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder. The Company received no cash consideration and paid no cash in connection with the transaction. See Note 2 and Note 6.

 

NOTE 8 – Related Party Transactions

 

The following is a summary of related party transactions for the three and nine months ended September 30, 2026 and 2025:

 

CEO salary waiver; standstill on preferred transfers/conversions. On December 31, 2025, Mr. MacGregor, the Company’s Chief Executive Officer and controlling stockholder, delivered a letter to the Company’s Board confirming that he is waiving any cash salary effective January 1, 2025 through March 31, 2026, unless the Board expressly approves otherwise in a written resolution executed after the date of the letter, and confirming a standstill on the sale, transfer, pledge, or conversion of his preferred shares during the same period. Mr. MacGregor has extended the salary waiver and preferred standstill through a date no later than December 31, 2026, which extension was accepted by the Board of Directors on August 13, 2026.

 

Professional fees / related party. During the three and nine months ended September 30, 2025, the Company incurred approximately $15,000 and $105,000, respectively, of professional fees to a legal firm affiliated with a former member of the Company’s Board of Directors. No services were rendered by the legal firm during the first nine months of 2026. At September 30, 2026 and December 31, 2025, the Company had approximately $136,000 and $146,000, respectively, included in accounts payable and accrued expenses owed to the legal firm.

 

F-12

 

 

Board consulting arrangements. During the three months ended September 30, 2026 and 2025, the Company had consulting services relationships with members of the Board of Directors whereby they were compensated a total of $0 and $15,000, respectively. During the nine months ended September 30, 2026 and 2025, the Company had consulting services relationships with members of the Board of Directors whereby they were compensated a total of $0 and $45,000, respectively. The consulting services were provided as requested by management and could be terminated at any time without penalty.

 

Loans / Mr. MacGregor and NMPFT. See Note 5 for related-party note balances and activity.

 

Director share purchase. On August 6, 2026, Timothy Battles, a member of the Board of Directors, purchased 500,000 shares of the Company’s common stock from the Company for cash at $0.10 per share, for aggregate proceeds of $50,000. See Note 6.

 

Transfers by principal stockholder. On August 6, 2026, The Noah Morgan Private Family Trust, a principal stockholder of the Company affiliated with the Company’s Chief Executive Officer, transferred an aggregate of 1,100,000 shares of common stock to unaffiliated transferees in privately negotiated transactions. The Company neither issued nor received any consideration in connection with these transfers, and they had no effect on the number of shares of common stock outstanding. Following the transfers, the trust held 20,036,048 shares of common stock.

 

NOTE 9 – Subsequent Events

 

Management has evaluated subsequent events through the date these condensed consolidated financial statements are issued.

 

Labrys standstill. On October 15 and 19, 2026, Labrys Fund II, L.P. confirmed by email that it will take no action under either of the Company’s promissory notes held by it, including no conversion, through November 20, 2026, in exchange for the Company’s payment by that date of the prior promissory note in full ($86,581.63, consisting of $85,204.35 of principal and interest through November 20, 2026) and a forbearance fee of $27,500, a total of $114,081.63. The January 20, 2026 note ($172,500 of principal and $17,250 of accrued interest) remains outstanding; its payment is not a condition of the standstill. If the payment is not received by November 20, 2026, Labrys has stated that it will convert on November 23, 2026 and treat both notes as in default. The forbearance fee was accrued at September 30, 2026 and is included in interest expense for the three and nine months then ended.

 

F-13

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements for a variety of reasons, including those set forth in our Annual Report on Form 10-K and in other filings with the SEC.

 

Overview

 

American Picture House Corporation is an entertainment company focused on the development, packaging, financing and production of feature films and limited series. During 2025, we pivoted away from third-party consulting to concentrate on internally developed projects and selective strategic partnerships. We generally pursue two complementary approaches to participating in projects: (i) structured film finance and senior or priority recoupment positions, including senior secured production lending and first-priority receipt structures designed to prioritize return of capital; and (ii) building an owned or controlled content library over time by acquiring or optioning intellectual properties and, where appropriate, obtaining negative ownership or other control rights in projects.

 

Recent Developments During the Nine Months Ended September 30, 2026

 

  ● On January 20, 2026, we completed a convertible note financing with Labrys Fund II, L.P. for a $150,000 purchase price, including $114,000 of cash proceeds to the Company after specified deductions and offsets, together with a 10% promissory note in the original principal amount of $172,500, 200,000 commitment shares, and an initial 12,000,000-share conversion reserve.
     
  ● Effective January 27, 2026, we entered into a Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC that revised our arrangement with respect to POSE, contemplated funding for MOTION, and contemplated an additional investment in an untitled SSS-produced picture, each subject to the terms of the agreement and applicable approvals.
     
  ● On March 12, 2026, our Board approved entry into the Multi-Film Agreement and ratified Amendment No. 1 to the APHP/SSS Agreement relating to POSE and BARRON’S COVE, effective December 29, 2025.
     
  ● PROTECTOR was released in U.S. theaters on March 6, 2026.
     
  ● Effective May 26, 2026, and executed on June 3, 2026, we entered into a Master Investment and Co-Production Agreement, together with related ancillary agreements, with Russ Posternak and Becky III The Movie LLC relating to the motion picture THE LAST TEMPTATION OF BECKY (referred to in the agreement as “BECKY 3”). Under the agreement, we are treated for all economic purposes as having made a $300,000 senior equity investment in the picture without funding any cash, entitling us to recoup 120% of that amount ($360,000) out of the picture waterfall on a senior equity basis, pari passu with up to $300,000 of other senior equity, together with a 10% distribution fee corridor participation, a 10% participation in the producer’s future BECKY-related producer fees and backend, an assignment of certain BARRON’S COVE collateral recovery rights, first look rights on future projects of the producer’s production company, and customary company and individual screen credits. As consideration, we agreed to issue 250,000 shares of common stock and to grant options to purchase 300,000 shares at $0.20 per share. The shares were issued on August 6, 2026. The options had not been issued as of the date of this report. See Note 7 and Note 6 to the condensed consolidated financial statements.
     
  ● During the nine months ended September 30, 2026, we applied $875,000 of amounts otherwise receivable by us toward our funding obligations under the Multi-Film Agreement, in exchange for content interests relating to MOTION and an untitled SSS-produced picture and in partial satisfaction of amounts payable with respect to POSE. The transaction did not involve the receipt or payment of cash. See Note 2 to the condensed consolidated financial statements and “Liquidity and Capital Resources — Produced and Licensed Content Costs” below.
     
  ● During the nine months ended September 30, 2026, Labrys Fund II, L.P. converted a portion of its prior promissory note into 162,600 shares of common stock. Scheduled amortization payments under the January 2026 note commenced July 20, 2026. As of the date of this report, the full principal amount of $172,500 of that note remained outstanding. See Note 4 to the condensed consolidated financial statements.

 

  ● The grant of options to purchase an aggregate of 700,000 shares of common stock, at an exercise price of $0.20 per share, to four designees of SSS Entertainment, LLC from the option pool contemplated under the Multi-Film Agreement remains subject to the conditions described in Note 6 to the condensed consolidated financial statements. None of those options had been granted as of the date of this report.

 

2
 

 

  ● On July 25, 2026, THE LAST TEMPTATION OF BECKY had its world premiere at the Fantasia International Film Festival in Montreal. The picture was released theatrically on November 4, 2026 by Quiver Distribution. As of the date of this report, we had collected no amounts in respect of our senior equity recoupment preference.
     
  ● On August 6, 2026, we issued an aggregate of 930,000 shares of common stock, consisting of 500,000 shares to Timothy Battles, a director, and 100,000 shares to an existing stockholder, in each case at $0.10 per share for cash; 80,000 shares to a consultant to the Company in consideration of services; and 250,000 shares to Russell Posternak pursuant to the Master Investment and Co-Production Agreement.
     
  ● MOTION is in final post-production; distribution arrangements had not been concluded as of the date of this report.

 

Recent Developments Subsequent to September 30, 2026

 

  ● On October 15 and 19, 2026, Labrys Fund II, L.P. agreed to a standstill through November 20, 2026 on both of the Company’s notes held by it, conditioned on the Company paying $114,081.63 by that date. See Note 9 to the condensed consolidated financial statements and “Liquidity and Capital Resources” below.
     
  ● See Note 9 to the condensed consolidated financial statements for additional information regarding events subsequent to September 30, 2026.

 

Results of Operations

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

 

The following table summarizes our results of operations for the three months ended September 30, 2026 and 2025:

 

   Three Months Ended September 30, 
   2026   2025   Change $ 
             
Revenues  $-   $-   $- 
                
Cost of revenues   -    -    - 
    -    -    - 
                
Operating Expenses:               
General and administrative   38,240    67,743    (29,503)
Research and development   -    -    - 
Sales and marketing   364    7,027    (6,663)
Total Operating Expenses   38,604    74,770    (36,166)
Net Operating Loss   (38,604)   (74,770)   36,166 
                
Other Income (Expenses):               
Interest income   -    -    - 
Interest expense   (68,120)   (30,787)   (37,333)
Net Other Income (Expenses)   (68,120)   (30,787)   (37,333)
Loss before income taxes   (106,724)   (105,557)   (1,167)
Income taxes   -    -    - 
Net loss  $(106,724)  $(105,557)  $(1,167)

 

Revenues. The Company had no revenues during the three months ended September 30, 2026 or 2025.

 

General and Administrative Expenses. General and administrative expenses for the three months ended September 30, 2026 were $38,240, compared with $67,743 for the three months ended September 30, 2025. The decrease of $29,503 reflects management’s efforts to reduce operational spend to conserve cash resources.

 

Sales and Marketing Expenses. Sales and marketing expenses were $364 for the three months ended September 30, 2026, compared with $7,027 for the comparable prior-year period.

 

Interest Expense. Interest expense was $68,120 for the three months ended September 30, 2026, compared with $30,787 for the three months ended September 30, 2025.

 

3
 

 

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

 

The following table summarizes our results of operations for the nine months ended September 30, 2026 and 2025:

 

   Nine Months Ended September 30, 
   2026   2025   Change $ 
             
Revenues  $1,220   $-   $1,220 
                
Cost of revenues   -    -    - 
    1,220    -    1,220 
                
Operating Expenses:               
General and administrative   207,377    1,293,606    (1,086,229)
Research and development   -    -    - 
Sales and marketing   4,150    8,857    (4,707)
Total Operating Expenses   211,527    1,302,463    (1,090,936)
Net Operating Loss   (210,307)   (1,302,463)   1,092,156 
                
Other Income (Expenses):               
Interest income   -    44    (44)
Interest expense   (139,114)   (52,603)   (86,511)
Net Other Income (Expenses)   (139,114)   (52,559)   (86,555)
Loss before income taxes   (349,421)   (1,355,022)   1,005,601 
Income taxes   -    -    - 
Net loss  $(349,421)  $(1,355,022)  $1,005,601 

 

Revenues. During the nine months ended September 30, 2026, revenues were $1,220, compared with $0 for the nine months ended September 30, 2025. The change was primarily attributable to income from the BUFFALOED CAMA.

 

General and Administrative Expenses. General and administrative expenses for the nine months ended September 30, 2026 were $207,377, compared with $1,293,606 for the nine months ended September 30, 2025. The 2025 period included $110,000 of stock-based compensation expense to a consultant, the write-off of $196,200 of loans receivable that management determined were uncollectible, and the expiration of rights to a screenplay carried on the books at $150,834. The 2025 period also included $379,065 of stock option expense compared to $0 in the 2026 period. These one-time expenses were offset by lower operational expenses including a $141,000 reduction in legal and professional fees and a $191,000 reduction in consulting fees

 

Sales and Marketing Expenses. Sales and marketing expenses for the nine months ended September 30, 2026 were $4,150, compared with $8,857 for the nine months ended September 30, 2025.

 

Interest Expense. Interest expense for the nine months ended September 30, 2026 was $139,114, compared with $52,603 for the prior-year period, with the change primarily attributable to the Labrys and Quick Capital financings.

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had no cash and cash equivalents, a book overdraft of $737 included in accounts payable and accrued expenses, a working capital deficit of $1,548,881, and an accumulated deficit of approximately $8.2 million. These conditions raise substantial doubt about our ability to continue as a going concern.

 

Operating Activities. During the nine months ended September 30, 2026, net cash used in operating activities was $84,124, compared with net cash used in operating activities of $325,877 for the same 2025 period. The 2026 period reflects $1,028,184 of collections on amounts due under the Company’s BARRON’S COVE revenue collection rights and $875,000 applied toward funding obligations under the Multi-Film Investment and Compensation Agreement.

 

Investing Activities. The Company had no investing activities during the nine months ended September 30, 2026 and 2025.

 

4
 

 

Financing Activities. During the nine months ended September 30, 2026, net cash provided by financing activities was $84,000. The 2026 period reflects net proceeds and repayments from promissory notes of $215,250 and $35,542, respectively, and $60,000 of proceeds from the sale of 600,000 shares of common stock. Additionally, during the first nine months of 2026, the Company borrowed and repaid $9,095 and $164,803 under related party notes payable. During the nine months ended September 30, 2025, net cash provided by financing activities was $427,752. The 2025 period reflects $115,000 of proceeds from a promissory note, $331,821 of borrowings and $20,119 of repayments under notes payable to related parties, and $1,050 of borrowings under the commercial line of credit.

 

Labrys Notes. Under the standstill described in Note 9, we must pay Labrys Fund II, L.P. $114,081.63 by November 20, 2026 to retire the prior promissory note and the forbearance fee; the January 20, 2026 note ($172,500 of principal and $17,250 of accrued interest) will remain outstanding. If the payment is not made, Labrys has stated that it will convert and treat both notes as in default, which would be dilutive to our stockholders and would accelerate our obligations under the notes. We intend to fund the payment from project receipts, advances from related parties or other financing, and there can be no assurance that such funds will be available by November 20, 2026. Labrys has advised that it is not in a position to extend further credit to the Company.

 

Funding Requirements. We expect our expenses to increase in connection with our ongoing film development and production activities and our public-company reporting obligations. We expect to finance operations and investments through a combination of project receipts, debt financings, equity issuances, and strategic transactions, although there can be no assurance that sufficient capital will be available on acceptable terms, or at all.

 

Critical Accounting Policies and Estimates

 

Our management’s discussion and analysis of financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. We believe our critical accounting policies and estimates include those related to revenue recognition, collectability of receivables, impairment of produced and licensed content costs and intangible assets, stock-based compensation, accounting for debt and equity-linked instruments, and contingencies.

 

Off-Balance Sheet Arrangements

 

None, except as may be described in the notes to the condensed consolidated financial statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, we are not required to provide the information otherwise required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and our principal financial officer, we carried out an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2026, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Chief Executive Officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026, due to the material weaknesses previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025, consisting of a lack of sufficient internal accounting personnel, a lack of segregation of duties, and a lack of sufficient internal controls (including information technology general controls) encompassing the Company as a whole at the entity and transaction levels to ensure complete documentation of complex and non-routine transactions and adequate financial reporting.

 

Management has identified corrective actions intended to address these material weaknesses, subject to the availability of financial resources, including engaging additional accounting and finance personnel or third-party accounting resources, enhancing documentation supporting complex and non-routine transactions, and formalizing review procedures over the preparation of periodic reports. Remediation efforts were not complete as of September 30, 2026 and remain ongoing. Because the Company’s ability to implement these measures depends in part on obtaining additional capital, there can be no assurance that such efforts will be successful or that they will fully address the material weaknesses identified.

 

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

5
 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On September 10 and September 12, 2025, respectively, ACME Film Company, an entity affiliated with Michael Jones, and Joncar Productions, Inc., an entity affiliated with Jonathan Sanger, the Company’s former President, submitted demands for arbitration against the Company to JAMS in Los Angeles, California (JAMS Ref. Nos. 5220010727 and 5220010741). Each demand arises out of a consulting agreement dated May 3, 2024 and seeks payment of consulting fees claimed to be due under that agreement. JAMS consolidated the matters under Ref. No. 5220010741 in December 2025. The Company disputes the claims and has objected to the commencement of the proceedings, the service of the demands, the arbitrator appointment process and the consolidation, reserving all rights, objections and defenses.

 

On August 18, 2026, Ameriprise Financial, Inc. filed a complaint in the United States District Court for the District of Massachusetts, captioned Ameriprise Financial, Inc. v. Barron’s Cove The Film, Inc., American Picture House Corporation and Bannor MacGregor, Case No. 1:26-cv-13816. The complaint alleges that Barron’s Cove The Film, Inc. breached a January 2024 agreement to sell approximately $1.2 million of Massachusetts film tax credits to the plaintiff, for which the plaintiff alleges it paid $995,507.92. It includes separate claims against the Company and Mr. MacGregor arising out of alleged interference, as to which the complaint seeks injunctive relief relating to the tax credit certificate and damages, including treble damages under M.G.L. c. 93A. On November 10, 2026, the parties filed a joint motion to extend the time for the Company and Mr. MacGregor to answer or otherwise respond to the complaint to December 18, 2026.

 

Other than the foregoing, there were no material developments during the quarter ended September 30, 2026 in any legal proceeding previously reported, and the Company is not a party to any other material pending legal proceeding.

 

Item 1A. Risk Factors

 

As a smaller reporting company, we are not required to provide the information otherwise required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Sales During the Quarter Ended September 30, 2026. On August 6, 2026, the Company issued an aggregate of 930,000 shares of common stock in transactions not involving any public offering. Of that amount, 250,000 shares were issued to the producer under the Master Investment and Co-Production Agreement relating to the motion picture THE LAST TEMPTATION OF BECKY as consideration for credits, branding rights and the economic entitlements granted to the Company under that agreement; and 680,000 shares were issued to three holders, consisting of 600,000 shares sold for cash at a price of $0.10 per share for aggregate gross proceeds of $60,000, and 80,000 shares issued as compensation for services rendered to the Company. The Company received $60,000 of gross proceeds, which were used for general working capital purposes, and no underwriting discounts or commissions were paid. The Company received no cash proceeds with respect to the shares issued under THE LAST TEMPTATION OF BECKY agreement or the shares issued for services. All of the securities were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder. Each recipient represented that the securities were being acquired for investment and not with a view to distribution, no general solicitation or general advertising was used, and the securities are subject to customary restrictive legends. The shares issued represented less than 1% of the Company’s outstanding common stock. See Note 6 and Note 7 to the condensed consolidated financial statements.

 

6
 

 

Of the 600,000 shares sold for cash, 500,000 shares were purchased by a member of the Company’s Board of Directors, who is an accredited investor within the meaning of Rule 501(a)(4) of Regulation D by virtue of his position as a director.

 

Item 3. Defaults Upon Senior Securities

 

Scheduled amortization payments under the Company’s January 20, 2026 promissory note to Labrys Fund II, L.P. were not made when due. As of the date of this report, the principal amount of $172,500 and accrued interest of $17,250 remained outstanding under that note, and $85,204.35 of principal remained outstanding under a prior note held by Labrys. Labrys has agreed to take no action under either note through November 20, 2026 on the terms described in Note 9 to the condensed consolidated financial statements.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

During the quarter ended September 30, 2026, there were no material changes to the procedures by which security holders may recommend nominees to the Company’s board of directors.

 

During the quarter ended September 30, 2026, no director or officer of the Company adopted, modified or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408 of Regulation S-K.

 

Item 6. Exhibits

 

Exhibit No.   Description
     
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.
32.2   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.
101   Inline XBRL/Interactive Data Files.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

7
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMERICAN PICTURE HOUSE CORPORATION

 

Date: November 13, 2026 By: /s/ Bannor Michael MacGregor
  Name: Bannor Michael MacGregor
  Title: Chief Executive Officer
     
Date: November 13, 2026 By: /s/ Daniel Hirsch
  Name: Daniel Hirsch
  Title: Principal Financial Officer / Chief Accounting Officer

 

8

 

Keep reading